ACTIVE

ENDO TOOLS THERAPEUTICS

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-9,9 M €-73,2 %over 1 year
Gross margin-2,2 M €+9,7 %over 1 year
Equity-15,1 M €-193,8 %over 1 year
Workforce19,4 ETP-8,1 %over 1 year

Identity

Source · BCE/KBO

ENDO TOOLS THERAPEUTICS is a Public limited company incorporated in 2008. Its registered office is in Charleroi. It employs on average 19,4 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0807.570.233
Incorporation
29/10/2008
Legal form
Public limited company
Registered office
Rue Clément Ader 10
6041 Charleroi · WallonieSee on map
Contributed capital
9 040 033,25 €
Latest accounts
31/12/2025
Average workforce
19,4 ETP
Joint committees (1)
  • 207
Contacts
3 public details availableLog in to view
Signals
Healthy social debts

Financials

Source · NBB, 17 filings

Trend over 17 financial years

20252024202320222021
Income statement
Gross margin-2,2 M €-2,5 M €-2,3 M €-1,7 M €-1,1 M €
EBITDA-4,3 M €-4,6 M €-4,1 M €-2,9 M €-2 M €
Operating result-5,4 M €-5,5 M €-4,9 M €-3,5 M €-2,4 M €
Net result-9,9 M €-5,7 M €-4,9 M €-3,5 M €-2,5 M €
Balance sheet
Equity-15,1 M €-5,1 M €609,2 k €5,5 M €5,9 M €
Total assets5,1 M €4,8 M €5,5 M €9,1 M €9 M €
Cash216,9 k €244 k €442,7 k €6,1 M €6,9 M €
Debts20,2 M €9,9 M €4,9 M €3,7 M €3,1 M €
Other
Workforce19,4 ETP21,1 ETP16,9 ETP11,4 ETP8,9 ETP

Board of directors

Source · NBB, accounts to 31/12/2025

8 active · 50 ended

Active mandates

MV Lifesciences

Director · since 02 septembre 2022 · until 09 juin 2028 · 0781.705.776

Represented by Michel Vanbrabant

Active
Alexandre Chau

Managing director · since 01 octobre 2020 · until 12 juin 2026

Active
Marc Nolet de Brauwere

Director · since 01 octobre 2020 · until 12 juin 2026

Active
ENDOMUNDI

Director · since 01 novembre 2019 · until 12 juin 2026 · 0736.382.131

Represented by Vincent Huberty

Active
DG International Consulting

Chairman of the board of directors · since 12 juin 2019 · until 12 juin 2026 · 0696.833.152

Represented by Denis Gestin

Active
MERCURY LEADERSHIP AND MANAGEMENT

Director · since 08 octobre 2018 · until 12 juin 2026 · 0640.709.051

Represented by Philippe Jean-Marie Léopold Degeer

Active
OLD MILL INVEST

Director · since 26 juin 2018 · until 12 juin 2026 · 0676.902.919

Represented by Mathieu Bocquet

Active
ODMC

Director · until 12 juin 2026 · 0897.279.989

Represented by Olivier Delporte

Active

Ended mandates

Alexandre Chau

Managing director · since 01 octobre 2020 · until 13 juin 2025

Ended
Marc Nolet de Brauwere

Director · since 01 octobre 2020 · until 13 juin 2025

Ended
ENDOMUNDI

Director · since 01 novembre 2019 · until 31 octobre 2025 · 0736.382.131

Represented by Vincent Huberty

Ended
DG International Consulting

Chairman of the board of directors · since 12 juin 2019 · until 12 juin 2025 · 0696.833.152

Represented by Denis Gestin

Ended

Other companies at this address

Rue Clément Ader 10 6041 Charleroi
CompanyCBE no.
2 Bridge WL● Active
1003.906.745
3D Fibroscreen● Active
1022.772.354
AdipoPharma Belgique● Active
1008.146.338
ATRYON BELGIUM● Active
0751.698.530
Brussels South Charleroi BioPark Dev● Active
0479.250.670
ConvEyXo● Active
0725.874.259
CONVEYXO GROUP● Active
1016.957.797
ELKEDONIA BELGIUM● Active
1021.635.177
Enodia Therapeutics Belgium● Active
1039.324.811
EU BIOTECH CAMPUS● Active
0776.668.706
Exo-Harvest● Active
0803.425.264
Hemastatx● Active
1019.406.058
Immunofusion● Active
0804.563.629
ImmunXperts● Active
0552.755.587
INCHINN THERAPEUTICS● Active
0799.914.755
INSTAR BELGIQUE● Active
1039.395.085
KOKUMA● Active
0799.078.377
LYS MEDICAL● Active
0688.626.061
MILEUTIS● Active
1011.400.984
Nexelis Europe● Active
0744.498.061

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date23/07/202627/06/202501/07/202428/06/202327/06/202224/06/2021
General meeting30/06/202624/06/202526/06/202422/06/202327/06/202223/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 17 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202623/07/2026FrenchPDF
Abridged model31/12/202424/06/202527/06/2025FrenchPDF
Abridged model31/12/202326/06/202401/07/2024FrenchPDF
Abridged model31/12/202222/06/202328/06/2023FrenchPDF
Abridged model31/12/202127/06/202227/06/2022FrenchPDF
Abridged model31/12/202023/06/202124/06/2021FrenchPDF
Abridged model31/12/201915/06/202006/07/2020FrenchPDF
Abridged model31/12/201812/06/201921/06/2019FrenchPDF
Abridged model31/12/201726/06/201803/07/2018FrenchPDF
Abridged model31/12/201626/06/201705/07/2017FrenchPDF
Abridged model31/12/201517/06/201628/06/2016FrenchPDF
Abridged model31/12/201426/06/201501/07/2015FrenchPDF
Abridged model31/12/201316/06/201426/06/2014FrenchPDF
Abridged model31/12/201214/06/201318/06/2013FrenchPDF
Abridged model31/12/201111/07/201216/07/2012FrenchPDF
Abridged model31/12/201007/07/201123/08/2011FrenchPDF
Abridged model31/12/200928/07/201031/08/2010FrenchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

8 active · 50 ended

Active mandates

MV Lifesciences

Director · since 02 septembre 2022 · until 09 juin 2028 · 0781.705.776

Represented by Michel Vanbrabant

Active
Alexandre Chau

Managing director · since 01 octobre 2020 · until 12 juin 2026

Active
Marc Nolet de Brauwere

Director · since 01 octobre 2020 · until 12 juin 2026

Active
ENDOMUNDI

Director · since 01 novembre 2019 · until 12 juin 2026 · 0736.382.131

Represented by Vincent Huberty

Active
DG International Consulting

Chairman of the board of directors · since 12 juin 2019 · until 12 juin 2026 · 0696.833.152

Represented by Denis Gestin

Active
MERCURY LEADERSHIP AND MANAGEMENT

Director · since 08 octobre 2018 · until 12 juin 2026 · 0640.709.051

Represented by Philippe Jean-Marie Léopold Degeer

Active
OLD MILL INVEST

Director · since 26 juin 2018 · until 12 juin 2026 · 0676.902.919

Represented by Mathieu Bocquet

Active
ODMC

Director · until 12 juin 2026 · 0897.279.989

Represented by Olivier Delporte

Active

Ended mandates

Alexandre Chau

Managing director · since 01 octobre 2020 · until 13 juin 2025

Ended
Marc Nolet de Brauwere

Director · since 01 octobre 2020 · until 13 juin 2025

Ended
ENDOMUNDI

Director · since 01 novembre 2019 · until 31 octobre 2025 · 0736.382.131

Represented by Vincent Huberty

Ended
DG International Consulting

Chairman of the board of directors · since 12 juin 2019 · until 12 juin 2025 · 0696.833.152

Represented by Denis Gestin

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates31/07/2026
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates17/12/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Registered office30/05/2024
    SIEGE SOCIAL
    PDF
  • Capital / shares24/10/2022
    CAPITAL, ACTIONS
    PDF
  • Mandates13/09/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates06/07/2022
    DEMISSIONS, NOMINATIONS - DIVERS
    PDF
  • Mandates06/01/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares08/02/2021
    CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-9,9 M €↓
  2. 2024
    Annual accounts 2024-5,7 M €↓
  3. 2023
    Annual accounts 2023-4,9 M €↓
  4. 2022
    Annual accounts 2022-3,5 M €↓
  5. 2021
    Annual accounts 2021-2,5 M €↓
  6. 2020
    Annual accounts 2020-2,3 M €↓
  7. 2019
    Annual accounts 2019-2 M €↓
  8. 2018
    Annual accounts 2018-1,6 M €↓
  9. 2017
    Annual accounts 2017-1,2 M €↓
  10. 2016
    Annual accounts 2016-979,7 k €↓
  11. 2015
    Annual accounts 2015-741 k €↓
  12. 2014
    Annual accounts 2014-649,1 k €↓
  13. 2013
    Annual accounts 2013-550 k €↓
  14. 2012
    Annual accounts 2012-317,5 k €↑
  15. 2011
    Annual accounts 2011-347,5 k €↓
  16. 2010
    Annual accounts 2010-277,5 k €↓
  17. 2009
    Annual accounts 2009-131,7 k €
  18. 29/10/2008
    IncorporationPublic limited company